Sophiris Bio Inc.

(SPHS) Trade

By |

Profile

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is a genetically modified recombinant protein which is selectively activated by enzymatically active prostate-specific antigen (PSA), which is only present in the prostate, leading to localized cell death and tissue disruption without damage to neighboring tissue and nerves. Geographically all the operations are functioned through the regions of Canada.

Contact Information

Website: www.sophirisbio.com
Email: ir@sophirisbio.com
Main Phone: +1 858 777-1760
Address: 1258 Prospect Street
State: CA
City / Town: La Jolla
Country: USA
Postal Code: 92037

Issuer Information

Exchange: NSC
CEO: Randall E. Woods
Employees: 6
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.14 $ -0.01 (-0.47%)
Last Price 2.14 Change $ -0.01 Change % -0.47 Tick N/A
Bid 2.13 Bid Size 100.00 Ask 2.14 Ask Size 400.00
Open 2.17 High 2.19 Low 2.08 Prev Close 2.15
Last Trade Volume 137,088 52 Wk Hi 4.05 52 Wk Low 1.72
Market Cap 64.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 30,111,153.00 EPS (TTM) -0.55 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 3
Number of Buys 0 3
Number of Sells 0 0
Net Activity 0 128763
Last 10 Buys Shares
Randall E. Woods 1,000
Gerald T. Proehl 1,000
Randall E. Woods 1,000
Randall E. Woods 1,000
Randall E. Woods 1,000
Peter T. Slover 1,000
Randall E. Woods 1,000
Last 10 Sell Shares
Lars G. Ekman 1,000
James L. Heppell 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8 8 8 8
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 6.75 6.75 6.75 6.75
Standard Deviation 0.96 0.96 0.96 0.96
Date of Most Recent Estimate 05/21/18 05/21/18 05/21/18 05/21/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1